Alphamab Oncology Announces IND Application for Innovative PD-L1/ VEGFR2 Bispecific ADC JSKN027 was Officially Accepted by CDE
SUZHOU, China, Dec. 18, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN027, an independently developed innovative bispecific antibody-drug conjugate (ADC) targeting...
Aksu accelerates the construction of the first microgrid demonstration project
AKSU, China, Nov. 26, 2024 /PRNewswire/ -- In order to further improve the reliability and stability of the power grid in remote areas, the State Grid Aksu Power Supply Company organized the first microgrid demonstration project review seminar in...